NVP 1103Alternative Names: NVP-1103
Latest Information Update: 03 Aug 2016
At a glance
- Originator Navipharm
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Asthma
Most Recent Events
- 03 Aug 2016 Early research in Asthma in South Korea (unspecified route)